Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: Interim report of a prospective randomized trial

被引:19
作者
Belli, LS
Alberti, AB
Rondinara, GF
de Carlis, L
Corti, A
Mazza, E
Airoldi, A
Cernuschi, A
de Gasperi, A
Forti, D
Pinzello, GB
机构
[1] Osped Niguarda Ca Granda, Div Med Crespi, I-20162 Milan, Italy
[2] Osped Niguarda Ca Granda, Div Chirurg Pizzamiglio 2, Ctr Trapianti Organi Addominali, I-20162 Milan, Italy
[3] Osped Niguarda Ca Granda, Serv Anestes, I-20162 Milan, Italy
关键词
D O I
10.1016/S0041-1345(00)02507-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1353 / 1354
页数:2
相关论文
共 5 条
  • [1] Demetris AJ, 1997, HEPATOLOGY, V25, P658
  • [2] ISHOCK K, 1995, J HEPATOL, V22, P696
  • [3] MAGRIN S, 1994, HEPATOLOGY, V19, P273
  • [4] SHEINER PA, 1995, HEPATOLOGY, V21, P30, DOI 10.1016/0270-9139(95)90404-2
  • [5] Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: Association with rejection and increased immunosuppression after transplantation
    Singh, N
    Gayowski, T
    Ndimbie, OK
    Nedjar, S
    Wagener, MM
    Yu, VL
    [J]. SURGERY, 1996, 119 (04) : 452 - 456